Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 600200 from our risk checks.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥8.29 |
52 Week High | CN¥13.88 |
52 Week Low | CN¥6.90 |
Beta | 0.12 |
11 Month Change | -7.48% |
3 Month Change | -24.36% |
1 Year Change | 8.94% |
33 Year Change | 1.72% |
5 Year Change | 70.93% |
Change since IPO | 48.04% |
Recent News & Updates
JiangSu WuZhong Pharmaceutical Development (SHSE:600200) Is Making Moderate Use Of Debt
Jun 06Many Still Looking Away From JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHSE:600200)
Mar 12Shareholder Returns
600200 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 1.2% | -5.9% | -3.0% |
1Y | 8.9% | -17.9% | -21.8% |
Return vs Industry: 600200 exceeded the CN Pharmaceuticals industry which returned -17.9% over the past year.
Return vs Market: 600200 exceeded the CN Market which returned -21.8% over the past year.
Price Volatility
600200 volatility | |
---|---|
600200 Average Weekly Movement | 5.7% |
Pharmaceuticals Industry Average Movement | 5.0% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 600200's share price has been volatile over the past 3 months.
Volatility Over Time: 600200's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 1,050 | Qunshan Qian | www.600200.com |
JiangSu WuZhong Pharmaceutical Development Co., Ltd. engages in pharmaceutical, medical cosmetology, investment, and other industries in China and internationally. It provides genetic and chemical drugs in the fields of anti-virus, anti infection, immune regulation, anti-tumor, digestive system, cardiovascular, etc.; and modern traditional Chinese medicine.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Fundamentals Summary
600200 fundamental statistics | |
---|---|
Market cap | CN¥5.84b |
Earnings (TTM) | -CN¥95.04m |
Revenue (TTM) | CN¥2.33b |
2.5x
P/S Ratio-61.4x
P/E RatioIs 600200 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
600200 income statement (TTM) | |
---|---|
Revenue | CN¥2.33b |
Cost of Revenue | CN¥1.80b |
Gross Profit | CN¥535.31m |
Other Expenses | CN¥630.35m |
Earnings | -CN¥95.04m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
Earnings per share (EPS) | -0.13 |
Gross Margin | 22.96% |
Net Profit Margin | -4.08% |
Debt/Equity Ratio | 101.8% |
How did 600200 perform over the long term?
See historical performance and comparison